Lefebvre Eric Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$6.92M

Insider Activity of Lefebvre Eric

Biography of Lefebvre Eric

No biography is available at this moment.

2025-01-17SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
18,478
0.0305%
$11.20$206,974-86.57%
2024-07-10SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
12,319
0.0223%
$11.56$142,408+2.03%
2024-01-17SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
10,295
0.0166%
$17.23$177,383-24.72%
2023-07-17SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
22,321
0.0402%
$18.01$401,981-14.41%
2023-03-30SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
11,245
0.02%
$26.52$298,228-35.4%
2023-01-23SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
67,500
0.1371%
$34.48$2.33M-39.7%
2022-12-20SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
10,887
0.0224%
$19.10$207,968-0.84%
2022-12-20SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
21,774
0.0447%
$19.10$415,936-0.84%
2022-10-25SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
10,000
0.0202%
$25.05$250,482-19.39%
2022-07-11SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
6,000
0.0111%
$20.00$120,000-3.91%
2021-06-18SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
25,000
0.0698%
$28.87$721,642-51.12%
2021-03-18SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
25,000
0.0695%
$39.41$985,355-54.37%
2020-12-18SalePliant Therapeutics, Inc.
PLRX
Chief Medical Officer
25,000
0.0733%
$26.54$663,503+2.31%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.